Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

BACKGROUND: Ketamine’s defining side effects are dissociation and increased blood pressure/heart rate. An oral formulation with delayed absorption could minimize these effects. We recently reported safety and tolerability data for an extended release ketamine tablet in healthy volunteers. METHODS: T...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Adv Psychopharmacol
Auteurs principaux: Glue, Paul, Medlicott, Natalie J., Neehoff, Shona, Surman, Peter, Lam, Fred, Hung, Noelyn, Hung, Cheung-tak
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2020
Sujets:
From Drug Misuse to Useful Drugs
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235665/
https://ncbi.nlm.nih.gov/pubmed/32523677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320922474
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires